Lung cell-specific modulation of LPS-induced TLR4 receptor and adaptor localization

Communicative and Integrative Biology

Volumn 7, Issue 5, 2014, Pages

  Sender, Vicky ^a   Stamme, Cordula ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Alveolar epithelial cells; Alveolar macrophages; Gram negative pneumonia; LPS; Lung innate immunity; Surfactant; Surfactant proteins; TLR receptor localization trafficking; Toll like receptor 4

Indexed keywords

EID: 84902956964     PISSN: 19420889     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.29053     Document Type: Review

References (95)

1. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005; 5:58-68.
2. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1998; 1408:79-89; PMID:9813251; http://dx.doi.org/10.1016/S0925-4439(98)00060-X
3. Pérez-Gil J. Structure of pulmonary surfactant membranes and films: the role of proteins and lipidprotein interactions. Biochim Biophys Acta 2008; 1778:1676-95; PMID:18515069; http://dx.doi.org/10.1016/j.bbamem.2008.05.003
4. LeVine AM, Whitsett JA. Pulmonary collectins and innate host defense of the lung. Microbes Infect 2001; 3:161-6.
5. Glasser SW, Maxfield MD, Ruetschilling TL, Akinbi HT, Baatz JE, Kitzmiller JA, Page K, Xu Y, Bao EL, Korfhagen TR. Persistence of LPS-induced lung inflammation in surfactant protein-C-deficient mice. Am J Respir Cell Mol Biol 2013; 49:845-54; PMID:23795648; http://dx.doi.org/10.1165/rcmb.2012-0374OC
6. Whitsett JA. Review: The intersection of surfactant homeostasis and innate host defense of the lung: lessons from newborn infants. Innate Immun 2010; 16:138-42; PMID:20351134; http://dx.doi.org/10.1177/1753425910366879
7. Koulenti D, Rello J. Gram-negative bacterial pneumonia:aetiology and management. Curr Opin Pulm Med 2006; 12:198-204; PMID:16582675
8. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-8; PMID:9851930; http://dx.doi.org/10.1126/science.282.5396.2085
9. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. Cutting edge: Tollike receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162:3749-52; PMID:10201887
10. Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, Florquin S, van der Poll T. Role of Tollike receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun 2004; 72:788-94; PMID:14742522; http://dx.doi.org/10.1128/IAI.72.2.788-794.2004
11. Schurr JR, Young E, Byrne P, Steele C, Shellito JE, Kolls JK. Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria. Infect Immun 2005; 73:532-45; PMID:15618193; http://dx.doi.org/10.1128/IAI.73.1.532-545.2005
12. Standiford LR, Standiford TJ, Newstead MJ, Zeng X, Ballinger MN, Kovach MA, Reka AK, Bhan U. TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol 2012; 302:L447-54; PMID:22160309; http://dx.doi.org/10.1152/ajplung.00415.2010
13. Power MR, Peng Y, Maydanski E, Marshall JS, Lin TJ. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J Biol Chem 2004; 279:49315-22; PMID:15375173; http://dx.doi.org/10.1074/jbc.M402111200
14. Wang X, Moser C, Louboutin JP, Lysenko ES, Weiner DJ, Weiser JN, Wilson JM. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol 2002; 168:810-5; PMID:11777976; http://dx.doi.org/10.4049/jimmunol.168.2.810
15. Jeyaseelan S, Young SK, Yamamoto M, Arndt PG, Akira S, Kolls JK, Worthen GS. Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa. J Immunol 2006; 177:538-47; PMID:16785551; http://dx.doi.org/10.4049/jimmunol.177.1.538
16. Cai S, Batra S, Shen L, Wakamatsu N, Jeyaseelan S. Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J Immunol 2009; 183:6629-38; PMID:19846873; http://dx.doi.org/10.4049/jimmunol.0901033
17. Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol 2004; 172:3377-81; PMID:15004134; http://dx.doi.org/10.4049/jimmunol.172.6.3377
18. Power MR, Li B, Yamamoto M, Akira S, Lin TJ. A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta in the host response to Pseudomonas aeruginosa lung infection in mice. J Immunol 2007; 178:3170-6; PMID:17312165; http://dx.doi.org/10.4049/jimmunol.178.5.3170
19. Wieland CW, Florquin S, Maris NA, Hoebe K, Beutler B, Takeda K, Akira S, van der Poll T. The MyD88- dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable Haemophilus influenzae from the mouse lung. J Immunol 2005; 175:6042-9; PMID:16237099; http://dx.doi.org/10.4049/jimmunol.175.9.6042
20. Jeyaseelan S, Manzer R, Young SK, Yamamoto M, Akira S, Mason RJ, Worthen GS. Toll-IL-1 receptor domain-containing adaptor protein is critical for early lung immune responses against Escherichia coli lipopolysaccharide and viable Escherichia coli. J Immunol 2005; 175:7484-95; PMID:16301656; http://dx.doi.org/10.4049/jimmunol.175.11.7484
21. Wieland CW, van Lieshout MH, Hoogendijk AJ, van der Poll T. Host defence during Klebsiella pneumonia relies on haematopoietic-expressed Toll-like receptors 4 and 2. Eur Respir J 2011; 37:848-57; PMID:20650991; http://dx.doi.org/10.1183/09031936.00076510
22. Detmers PA, Thieblemont N, Vasselon T, Pironkova R, Miller DS, Wright SD. Potential role of membrane internalization and vesicle fusion in adhesion of neutrophils in response to lipopolysaccharide and TNF. J Immunol 1996; 157:5589-96; PMID:8955211
23. Thiéblemont N, Wright SD. Mice genetically hyporesponsive to lipopolysaccharide (LPS) exhibit a defect in endocytic uptake of LPS and ceramide. J Exp Med 1997; 185:2095-100; PMID:9182681; http://dx.doi.org/10.1084/jem.185.12.2095
24. Thieblemont N, Thieringer R, Wright SD. Innate immune recognition of bacterial lipopolysaccharide:dependence on interactions with membrane lipids and endocytic movement. Immunity 1998; 8:771-7; PMID:9655491; http://dx.doi.org/10.1016/S1074-7613(00)80582-8
25. Barton GM, Kagan JC. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 2009; 9:535-42; PMID:19556980; http://dx.doi.org/10.1038/nri2587
26. McGettrick AF, O'Neill LA. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol 2010; 22:20-7; PMID:20060278; http://dx.doi.org/10.1016/j.coi.2009.12.002
27. Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, Espevik T. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 2002; 277:47834-43; PMID:12324469; http://dx.doi.org/10.1074/jbc.M207873200
28. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002; 3:667-72; PMID:12055629
29. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 2002; 115:2603-11; PMID:12045230
30. Triantafilou M, Morath S, Mackie A, Hartung T, Triantafilou K. Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci 2004; 117:4007-14; PMID:15286178; http://dx.doi.org/10.1242/jcs.01270
31. Kagan JC, Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006; 125:943-55; PMID:16751103; http://dx.doi.org/10.1016/j.cell.2006.03.047
32. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Tolllike receptor 4 to the induction of interferon-beta. Nat Immunol 2008; 9:361-8; PMID:18297073; http://dx.doi.org/10.1038/ni1569
33. Tanimura N, Saitoh S, Matsumoto F, Akashi-Takamura S, Miyake K. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys Res Commun 2008; 368:94-9; PMID:18222170; http://dx.doi.org/10.1016/j.bbrc.2008.01.061
34. Husebye H, Halaas Ø, Stenmark H, Tunheim G, Sandanger Ø, Bogen B, Brech A, Latz E, Espevik T. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 2006; 25:683-92; PMID:16467847; http://dx.doi.org/10.1038/sj.emboj.7600991
35. Thieblemont N, Wright SD. Transport of bacterial lipopolysaccharide to the golgi apparatus. J Exp Med 1999; 190:523-34; PMID:10449523; http://dx.doi.org/10.1084/jem.190.4.523
36. Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011; 147:868-80; PMID:22078883; http://dx.doi.org/10.1016/j.cell.2011.09.051
37. Aksoy E, Taboubi S, Torres D, Delbauve S, Hachani A, Whitehead MA, Pearce WP, Berenjeno IM, Nock G, Filloux A, et al. The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat Immunol 2012; 13:1045-54; PMID:23023391; http://dx.doi.org/10.1038/ni.2426
38. Palsson-McDermott EM, Doyle SL, McGettrick AF, Hardy M, Husebye H, Banahan K, Gong M, Golenbock D, Espevik T, O'Neill LA. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. Nat Immunol 2009; 10:579-86; PMID:19412184; http://dx.doi.org/10.1038/ni.1727
39. Doyle SL, Husebye H, Connolly DJ, Espevik T, O'Neill LA, McGettrick AF. The GOLD domaincontaining protein TMED7 inhibits TLR4 signalling from the endosome upon LPS stimulation. Nat Commun 2012; 3:707; PMID:22426228; http://dx.doi.org/10.1038/ncomms1706
40. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 2009; 10:513-25; PMID:19603039; http://dx.doi.org/10.1038/nrm2728
41. Progida C, Cogli L, Piro F, De Luca A, Bakke O, Bucci C. Rab7b controls trafficking from endosomes to the TGN. J Cell Sci 2010; 123:1480-91; PMID:20375062; http://dx.doi.org/10.1242/jcs.051474
42. Wang Y, Chen T, Han C, He D, Liu H, An H, Cai Z, Cao X. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4. Blood 2007; 110:962-71; PMID:17395780; http://dx.doi.org/10.1182/blood-2007-01-066027
43. Wang D, Lou J, Ouyang C, Chen W, Liu Y, Liu X, Cao X, Wang J, Lu L. Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membrane. Proc Natl Acad Sci U S A 2010; 107:13806-11; PMID:20643919; http://dx.doi.org/10.1073/pnas.1009428107
44. Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas O, Nilsen NJ, Stenmark H, Latz E, Lien E, et al. The Rab11a GTPase controls Tolllike receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 2010; 33:583-96; PMID:20933442; http://dx.doi.org/10.1016/j.immuni.2010.09.010
45. Ferguson JS, Martin JL, Azad AK, McCarthy TR, Kang PB, Voelker DR, Crouch EC, Schlesinger LS. Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect Immun 2006; 74:7005-9; PMID:17030585; http://dx.doi.org/10.1128/IAI.01402-06
46. Sawada K, Ariki S, Kojima T, Saito A, Yamazoe M, Nishitani C, Shimizu T, Takahashi M, Mitsuzawa H, Yokota S, et al. Pulmonary collectins protect macrophages against pore-forming activity of Legionella pneumophila and suppress its intracellular growth. J Biol Chem 2010; 285:8434-43; PMID:20056602; http://dx.doi.org/10.1074/jbc.M109.074765
47. Sender V, Moulakakis C, Stamme C. Pulmonary surfactant protein A enhances endolysosomal trafficking in alveolar macrophages through regulation of Rab7. J Immunol 2011; 186:2397-411; PMID:21248257; http://dx.doi.org/10.4049/jimmunol.1002446
48. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008; 133:235-49; PMID:18423196; http://dx.doi.org/10.1016/j.cell.2008.02.043
49. Fan J, Kapus A, Marsden PA, Li YH, Oreopoulos G, Marshall JC, Frantz S, Kelly RA, Medzhitov R, Rotstein OD. Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J Immunol 2002; 168:5252-9; PMID:11994482; http://dx.doi.org/10.4049/jimmunol.168.10.5252
50. Oshikawa K, Sugiyama Y. Gene expression of Tollike receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem Biophys Res Commun 2003; 305:649-55; PMID:12763043; http://dx.doi.org/10.1016/S0006-291X(03)00837-4
51. Punturieri A, Alviani RS, Polak T, Copper P, Sonstein J, Curtis JL. Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages. J Immunol 2004; 173:1033-42; PMID:15240691; http://dx.doi.org/10.4049/jimmunol.173.2.1033
52. Saito T, Yamamoto T, Kazawa T, Gejyo H, Naito M. Expression of toll-like receptor 2 and 4 in lipopolysaccharide- induced lung injury in mouse. Cell Tissue Res 2005; 321:75-88; PMID:15902499; http://dx.doi.org/10.1007/s00441-005-1113-9
53. Sender V, Lang L, Stamme C. Surfactant protein-A modulates LPS-induced TLR4 localization and signaling via β-arrestin 2. PLoS One 2013; 8:e59896; PMID:23536892; http://dx.doi.org/10.1371/journal.pone.0059896
54. Hollingsworth JW, Chen BJ, Brass DM, Berman K, Gunn MD, Cook DN, Schwartz DA. The critical role of hematopoietic cells in lipopolysaccharideinduced airway lammation. Am J Respir Crit Care Med 2005; 171:806-13; PMID:15618460; http://dx.doi.org/10.1164/rccm.200407-953OC
55. Srivastava M, Jung S, Wilhelm J, Fink L, Bühling F, Welte T, Bohle RM, Seeger W, Lohmeyer J, Maus UA. The inflammatory versus constitutive trafficking of mononuclear phagocytes into the alveolar space of mice is associated with drastic changes in their gene expression profiles. J Immunol 2005; 175:1884-93; PMID:16034132; http://dx.doi.org/10.4049/jimmunol.175.3.1884
56. Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005; 6:68; PMID:16004610; http://dx.doi.org/10.1186/1465-9921-6-68
57. Juarez E, Nuñez C, Sada E, Ellner JJ, Schwander SK, Torres M. Differential expression of Tollike receptors on human alveolar macrophages and autologous peripheral monocytes. Respir Res 2010; 11:2; PMID:20051129; http://dx.doi.org/10.1186/1465-9921-11-2
58. Thorley AJ, Grandolfo D, Lim E, Goldstraw P, Young A, Tetley TD. Innate immune responses to bacterial ligands in the peripheral human lung--role of alveolar epithelial TLR expression and signalling. PLoS One 2011; 6:e21827; PMID:21789185; http://dx.doi.org/10.1371/journal.pone.0021827
59. Maris NA, Dessing MC, de Vos AF, Bresser P, van der Zee JS, Jansen HM, Spek CA, van der Poll T. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur Respir J 2006; 28:622-6; PMID:16946093; http://dx.doi.org/10.1183/09031936.06.00010806
60. Hoogerwerf JJ, de Vos AF, van't Veer C, Bresser P, de Boer A, Tanck MW, Draing C, van der Zee JS, van der Poll T. Priming of alveolar macrophages upon instillation of lipopolysaccharide in the human lung. Am J Respir Cell Mol Biol 2010; 42:349-56; PMID:19448156; http://dx.doi.org/10.1165/rcmb.2008-0362OC
61. Wong MH, Chapin OC, Johnson MD. LPSstimulated cytokine production in type I cells is modulated by the renin-angiotensin system. Am J Respir Cell Mol Biol 2012; 46:641-50; PMID:22205632; http://dx.doi.org/10.1165/rcmb.2011-0289OC
62. Wong MH, Johnson MD. Differential response of primary alveolar type I and type II cells to LPS stimulation. PLoS One 2013; 8:e55545; PMID:23383221; http://dx.doi.org/10.1371/journal.pone.0055545
63. Schulz C, Farkas L, Wolf K, Kratzel K, Eissner G, Pfeifer M. Differences in LPS-induced activation of bronchial epithelial cells (BEAS-2B) and type II-like pneumocytes (A-549). Scand J Immunol 2002; 56:294-302; PMID:12193231; http://dx.doi.org/10.1046/j.1365-3083.2002.01137.x
64. Becker MN, Diamond G, Verghese MW, Randell SH. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 2000; 275:29731-6; PMID:10882713; http://dx.doi.org/10.1074/jbc.M000184200
65. Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M, Si-Tahar M. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 2004; 279:2712-8; PMID:14600154; http://dx.doi.org/10.1074/jbc.M305790200
66. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, Millar AB. Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004; 31:241-5; PMID:15044215; http://dx.doi.org/10.1165/rcmb.2004-0078OC
67. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176:1665-71; PMID:1281215; http://dx.doi.org/10.1084/jem.176.6.1665
68. Henning LN, Azad AK, Parsa KV, Crowther JE, Tridandapani S, Schlesinger LS. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J Immunol 2008; 180:7847-58; PMID:18523248; http://dx.doi.org/10.4049/jimmunol.180.12.7847
69. Abate W, Alghaithy AA, Parton J, Jones KP, Jackson SK. Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains. J Lipid Res 2010; 51:334-44; PMID:19648651; http://dx.doi.org/10.1194/jlr.M000513
70. Kobayashi H, Nolan A, Naveed B, Hoshino Y, Segal LN, Fujita Y, Rom WN, Weiden MD. Neutrophils activate alveolar macrophages by producing caspase-6-mediated cleavage of IL-1 receptor-associated kinase-M. J Immunol 2011; 186:403-10; PMID:21098228; http://dx.doi.org/10.4049/jimmunol.1001906
71. Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, Shevde NK, Segal D, Dzivenu OK, Vologodskaia M, Yim M, et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 2002; 418:443-7; PMID:12140561; http://dx.doi.org/10.1038/nature00888
72. Deng JC, Cheng G, Newstead MW, Zeng X, Kobayashi K, Flavell RA, Standiford TJ. Sepsisinduced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest 2006; 116:2532-42; PMID:16917541
73. Nguyen HA, Rajaram MV, Meyer DA, Schlesinger LS. Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages. Am J Physiol Lung Cell Mol Physiol 2012; 303:L608-16; PMID:22886503; http://dx.doi.org/10.1152/ajplung.00067.2012
74. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, Hokamp K, Roche FM, Mu R, Doho GH, Pistolic J, et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 2006; 176:2455-64; PMID:16456005; http://dx.doi.org/10.4049/jimmunol.176.4.2455
75. Shaykhiev R, Sierigk J, Herr C, Krasteva G, Kummer W, Bals R. The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS. FASEB J 2010; 24:4756-66; PMID:20696857; http://dx.doi.org/10.1096/fj.09-151332
76. Li D, Liu Y, Yang Y, Chen JH, Yang J, Zou LY, Tian ZQ, Lv J, Xia PY. Looped host defense peptide CLP-19 binds to microtubules and inhibits surface expression of TLR4 on mouse macrophages. J Immunol 2013; 190:6083-92; PMID:23667111; http://dx.doi.org/10.4049/jimmunol.1203167
77. Suzuki M, Tachibana I, Takeda Y, He P, Minami S, Iwasaki T, Kida H, Goya S, Kijima T, Yoshida M, et al. Tetraspanin CD9 negatively regulates lipopolysaccharide- induced macrophage activation and lung inflammation. J Immunol 2009; 182:6485-93; PMID:19414803; http://dx.doi.org/10.4049/jimmunol.0802797
78. Powers KA, Szászi K, Khadaroo RG, Tawadros PS, Marshall JC, Kapus A, Rotstein OD. Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med 2006; 203:1951-61; PMID:16847070; http://dx.doi.org/10.1084/jem.20060943
79. Kaksonen M, Toret CP, Drubin DG. Harnessing actin dynamics for clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 2006; 7:404-14; PMID:16723976; http://dx.doi.org/10.1038/nrm1940
80. Ikeda K, Kundu RK, Ikeda S, Kobara M, Matsubara H, Quertermous T. Glia maturation factor-gamma is preferentially expressed in microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization. Circ Res 2006; 99:424-33; PMID:16873721; http://dx.doi.org/10.1161/01.RES.0000237662.23539.0b
81. Aerbajinai W, Lee K, Chin K, Rodgers GP. Glia maturation factor-γ negatively modulates TLR4 signaling by facilitating TLR4 endocytic trafficking in macrophages. J Immunol 2013; 190:6093-103; PMID:23677465; http://dx.doi.org/10.4049/jimmunol.1203048
82. Oldenburger A, Maarsingh H, Schmidt M. Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung. Pharmaceuticals (Basel) 2012; 5:1291-331; PMID:24281338; http://dx.doi.org/10.3390/ph5121291
83. Cai W, Du A, Feng K, Zhao X, Qian L, Ostrom RS, Xu C. Adenylyl cyclase 6 activation negatively regulates TLR4 signaling through lipid raft-mediated endocytosis. J Immunol 2013; 191:6093-100; PMID:24218452; http://dx.doi.org/10.4049/jimmunol.1301912
84. Ferwerda B, McCall MB, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, Izagirre N, Syafruddin D, Kibiki G, Cristea T, Hijmans A, et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A 2007; 104:16645-50; PMID:17925445; http://dx.doi.org/10.1073/pnas.0704828104
85. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25:187-91; PMID:10835634; http://dx.doi.org/10.1038/76048
86. Kumpf O, Giamarellos-Bourboulis EJ, Koch A, Hamann L, Mouktaroudi M, Oh DY, Latz E, Lorenz E, Schwartz DA, Ferwerda B, et al. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release:an observational study in three cohorts. Crit Care 2010; 14:R103; PMID:20525286; http://dx.doi.org/10.1186/cc9047
87. Ohto U, Yamakawa N, Akashi-Takamura S, Miyake K, Shimizu T. Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I. J Biol Chem 2012; 287:40611-7; PMID:23055527; http://dx.doi.org/10.1074/jbc.M112.404608
88. Figueroa L, Xiong Y, Song C, Piao W, Vogel SN, Medvedev AE. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J Immunol 2012; 188:4506-15; PMID:22474023; http://dx.doi.org/10.4049/jimmunol.1200202
89. Campodónico VL, Gadjeva M, Paradis-Bleau C, Uluer A, Pier GB. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol Med 2008; 14:120-33; PMID:18262467; http://dx.doi.org/10.1016/j.molmed.2008.01.002
90. Bruscia EM, Zhang PX, Satoh A, Caputo C, Medzhitov R, Shenoy A, Egan ME, Krause DS. Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis. J Immunol 2011; 186:6990-8; PMID:21593379; http://dx.doi.org/10.4049/jimmunol.1100396
91. Kelly C, Canning P, Buchanan PJ, Williams MT, Brown V, Gruenert DC, Elborn JS, Ennis M, Schock BC. Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2013; 304:L371-82; PMID:23316065; http://dx.doi.org/10.1152/ajplung.00372.2011
92. Hortal J, Muñoz P, Cuerpo G, Litvan H, Rosseel PM, Bouza E; European Study Group on Nosocomial Infections; European Workgroup of Cardiothoracic Intensivists. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care 2009; 13:R80; PMID:19463176; http://dx.doi.org/10.1186/cc7896
93. Chalk K, Meisel C, Spies C, Volk T, Thuenemann K, Linneweber J, Wernecke KD, Sander M. Dysfunction of alveolar macrophages after 3 cardiac surgery and postoperative pneumonia? - an 5 observational study. Crit Care 2013; 17:R285; PMID:24321282; http://dx.doi.org/10.1186/cc13148
94. Hatzidaki E, Nakos G, Galiatsou E, Lekka ME. Impaired phospholipases A2production by stimulated macrophages from patients with acute respiratory distress syndrome. Biochim Biophys Acta 2010; 1802:986-94; PMID:20600872; http://dx.doi.org/10.1016/j.bbadis.2010.06.008
95. Tang L, Li Q, Bai J, Zhang H, Lu Y, Ma S. Severe pneumonia mortality in elderly patients is associated with downregulation of Toll-like receptors 2 and 4 on monocytes. Am J Med Sci 2014; 347:34-41; PMID:23406892; http://dx.doi.org/10.1097/MAJ.0b013e3182798583